Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 2016-2026

  García Angulo, Víctor A ^a   Kalita, Anjana ^a   Kalita, Mridul ^b   Lozano, Luis ^c   Torres, Alfredo G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; DNA VACCINE; ENTEROHEMORRHAGIC ESCHERICHIA COLI VACCINE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PILIN; RANTES; STRUCTURAL PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL LOAD; BACTERIAL STRAIN; BIOINFORMATICS; COMPARATIVE GENOMICS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GASTROINTESTINAL INFECTION; GENETIC CODE; GENOMICS; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; TYPE III SECRETION SYSTEM; VACCINATION; WILD TYPE;

ANIMALS; CECUM; COMPUTATIONAL BIOLOGY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI VACCINES; FECES; FEMALE; GENOME, BACTERIAL; GENOMICS; MICE; MICE, INBRED BALB C; TRANSCRIPTOME;

EID: 84898927577     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01437-13     Document Type: Article

References (66)

1. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
2. Farfan MJ, Torres AG. 2012. Molecular mechanisms that mediate colonization of Shiga toxin-producing Escherichia coli strains. Infect. Immun. 80:903-913. http://dx.doi.org/10.1128/IAI.05907-11.
3. Nguyen Y, Sperandio V. 2012. Enterohemorrhagic Escherichia coli (EHEC) pathogenesis. Front. Cell Infect. Microbiol. 2:90. http://dx.doi.org/10.3389/fcimb.2012.00090.
4. Garcia-Angulo VA, Kalita A, Torres AG. 2013. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection. Vaccine 31:3229-3235. http://dx.doi.org/10.1016/j.vaccine.2013.05.013.
5. Marks HM, Tohamy SM, Tsui F. 2013. Modeling uncertainty of estimated illnesses attributed to non-O157:H7 Shiga toxin-producing Escherichia coli and its impact on illness cost. J. Food Prot. 76:945-952. http: //dx.doi.org/10.4315/0362-028X.JFP-12-409.
6. Karmali MA, Gannon V, Sargeant JM. 2010. Verocytotoxin-producing Escherichia coli (VTEC). Vet. Microbiol. 140:360-370. http://dx.doi.org /10.1016/j.vetmic.2009.04.011.
7. Pacheco AR, Sperandio V. 2012. Shiga toxin in enterohemorrhagic Escherichia coli: regulation and novel anti-virulence strategies. Front. Cell Infect. Microbiol. 2:81.
8. Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL. 2011. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol. Microbiol. 80:1420-1438. http://dx.doi.org/10.1111/j.1365-2958.2011.07661.x.
9. Sekiya K, Ohishi M, Ogino T, Tamano K, Sasakawa C, Abe A. 2001. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. U. S. A. 98:11638-11643. http://dx.doi.org/10.1073/pnas.191378598.
10. Spreter T, Yip CK, Sanowar S, André I, Kimbrough TG, Vuckovic M, Pfuetzner RA, Deng W, Yu AC, Finlay BB, Baker D, Miller SI, Strynadka NC. 2009. A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system. Nat. Struct. Mol. Biol. 16:468-476. http://dx.doi.org/10.1038/nsmb.1603.
11. Tree JJ, Wolfson EB, Wang D, Roe AJ, Gally DL. 2009. Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli. Trends Microbiol. 17:361-370. http://dx.doi.org/10.1016/j.tim.2009.06.001.
12. Walle KV, Vanrompay D, Cox E. 2012. Bovine innate and adaptive immune responses against Escherichia coli O157:H7 and vaccination strategies to reduce faecal shedding in ruminants. Vet. Immunol. Immunopathol. 152:109-120. http://dx.doi.org/10.1016/j.vetimm.2012.09.028.
13. Varela NP, Dick P, Wilson J. 2013. Assessing the existing information on the efficacy of bovine vaccination against Escherichia coli O157:H7: a systematic review and meta-analysis. Zoonoses Public Health 60:253-268. http://dx.doi.org/10.1111/j.1863-2378.2012.01523.x.
14. Snedeker KG, Campbell M, Sargeant JM. 2012. A systematic review of vaccinations to reduce the shedding of Escherichia coli O157 in the faeces of domestic ruminants. Zoonoses Public Health 59:126-138. http://dx.doi.org/10.1111/j.1863-2378.2011.01426.x.
15. Ishikawa S, Kawahara K, Kagami Y, Isshiki Y, Kaneko A, Matsui H, Okada N, Danbara H. 2003. Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1. Infect. Immun. 71:3235-3239. http://dx.doi.org/10.1128/IAI.71.6.3235-3239.2003.
16. Marcato P, Mulvey G, Read RJ, Vander Helm K, Nation PN, Armstrong GD. 2001. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit. J. Infect. Dis. 183:435-443. http://dx.doi.org/10.1086/318080.
17. Cai K, Gao X, Li T, Wang Q, Hou X, Tu W, Xiao L, Tian M, Liu Y, Wang H. 2011. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection. Vaccine 29:946-952. http://dx.doi.org/10.1016/j.vaccine.2010.11.035.
18. Bentancor LV, Bilen M, Brando RJ, Ramos MV, Ferreira LC, Ghiringhelli PD, Palermo MS. 2009. A DNA vaccine encoding the enterohemorrhagic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model. Clin. Vaccine Immunol. 16:712-718. http://dx.doi.org/10.1128/CVI.00328-08.
19. Rojas RL, Gomes PA, Bentancor LV, Sbrogio-Almeida ME, Costa SO, Massis LM, Ferreira RC, Palermo MS, Ferreira LC. 2010. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clin. Vaccine Immunol. 17:529-536. http://dx.doi.org/10.1128/CVI.00495-09.
20. Cheng Y, Feng Y, Luo P, Gu J, Yu S, Zhang WJ, Liu YQ, Wang QX, Zou QM, Mao XH. 2009. Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development. J. Microbiol. 47:498-505. http://dx.doi.org/10.1007/s12275-009-0116-8.
21. Gu J, Liu Y, Yu S, Wang H, Wang Q, Yi Y, Zhu F, Yu XJ, Zou Q, Mao X. 2009. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Microbes Infect. 11:835-841. http://dx.doi.org/10.1016/j.micinf.2009.04.024.
22. Gu J, Ning Y, Wang H, Xiao D, Tang B, Luo P, Cheng Y, Jiang M, Li N, Zou Q, Mao X. 2011. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice. Vaccine 29:7395-7403. http://dx.doi.org/10.1016/j.vaccine.2011.07.069.
23. Zhang XH, He KW, Zhang SX, Lu WC, Zhao PD, Luan XT, Ye Q, Wen LB, Li B, Guo RL, Wang XM, Lv LX, Zhou JM, Yu ZY, Mao AH. 2011. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice. Vaccine 29:3923-3939. http://dx.doi.org/10.1016/j.vaccine.2011.02.007.
24. Zhang XH, He KW, Zhao PD, Ye Q, Luan XT, Yu ZY, Wen LB, Ni YX, Li B, Wang XM, Guo RL, Zhou JM, Mao AH. 2012. Intranasal immunization with Stx2B-Tir-Stx1B-Zot protein leads to decreased shedding in goats after challenge with Escherichia coli O157:H7. Vet. Rec. 170:178. http://dx.doi.org/10.1136/vr.100325.
25. Gao X, Cai K, Shi J, Liu H, Hou X, Tu W, Xiao L, Wang Q, Wang H. 2009. Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection. Vaccine 27:2070-2076. http://dx.doi.org/10.1016/j.vaccine.2009.01.115.
26. Gao X, Cai K, Li T, Wang Q, Hou X, Tian R, Liu H, Tu W, Xiao L, Fang L, Luo S, Liu Y, Wang H. 2011. Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice. Vaccine 29:6656-6663. http://dx.doi.org/10.1016/j.vaccine.2011.06.106.
27. Mejias MP, Ghersi G, Craig PO, Panek CA, Bentancor LV, Baschkier A, Goldbaum FA, Zylberman V, Palermo MS. 2013. Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice. J. Immunol. 191:2403-2411. http://dx.doi.org/10.4049/jimmunol.1300999.
28. Abu-Ali GS, Ouellette LM, Henderson ST, Lacher DW, Riordan JT, Whittam TS, Manning SD. 2010. Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS One 5:e10167. http://dx.doi.org/10.1371/journal.pone.0010167.
29. Neupane M, Abu-Ali GS, Mitra A, Lacher DW, Manning SD, Riordan JT. 2011. Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease. Microb. Pathog. 51:466-470. http: //dx.doi.org/10.1016/j.micpath.2011.07.009.
30. Arthur TM, Ahmed R, Chase-Topping M, Kalchayanand N, Schmidt JW, Bono JL. 2013. Characterization of Escherichia coli O157:H7 strains isolated from supershedding cattle. Appl. Environ. Microbiol. 79:4294-4303. http://dx.doi.org/10.1128/AEM.00846-13.
31. Matthews L, Reeve R, Woolhouse ME, Chase-Topping M, Mellor DJ, Pearce MC, Allison LJ, Gunn GJ, Low JC, Reid SW. 2009. Exploiting strain diversity to expose transmission heterogeneities and predict the impact of targeting supershedding. Epidemics 1:221-229. http://dx.doi.org/10.1016/j.epidem.2009.10.002.
32. Matthews L, Reeve R, Gally DL, Low JC, Woolhouse ME, McAteer SP, Locking ME, Chase-Topping ME, Haydon DT, Allison LJ, Hanson MF, Gunn GJ, Reid SW. 2013. Predicting the public health benefit of vaccinating cattle against Escherichia coli O157. Proc. Natl. Acad. Sci. U. S. A. 110:16265-16270. http://dx.doi.org/10.1073/pnas.1304978110.
33. Tarr PI, Neill MA, Clausen CR, Newland JW, Neill RJ, Moseley SL. 1989. Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987. J. Infect. Dis. 159:344-347. http: //dx.doi.org/10.1093/infdis/159.2.344.
34. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685. http://dx.doi.org/10.1056/NEJM198303243081203.
35. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305:567-580. http://dx.doi.org/10.1006/jmbi.2000.4315.
36. Tusnady GE, Simon I. 2001. The HMMTOP transmembrane topology prediction server. Bioinformatics 17:849-850. http://dx.doi.org/10.1093 /bioinformatics/17.9.849.
37. Kall L, Krogh A, Sonnhammer EL. 2007. Advantages of combined transmembrane topology and signal peptide prediction: the Phobius web server. Nucleic Acids Res. 35:W429-W432. http://dx.doi.org/10.1093/nar /gkm256.
38. Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, Dao P, Sahinalp SC, Ester M, Foster LJ, Brinkman FS. 2010. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26:1608-1615. http://dx.doi.org/10.1093/bioinformatics/btq249.
39. Petersen TN, Brunak S, von Heijne G, Nielsen H. 2011. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 8:785-786. http://dx.doi.org/10.1038/nmeth.1701.
40. Kesmir C, Nussbaum AK, Schild H, Detours V, Brunak S. 2002. Prediction of proteasome cleavage motifs by neural networks. Protein Eng. 15:287-296. http://dx.doi.org/10.1093/protein/15.4.287.
41. Juncker AS, Willenbrock H, Von Heijne G, Brunak S, Nielsen H, Krogh A. 2003. Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci. 12:1652-1662. http://dx.doi.org/10.1110/ps.0303703.
42. Berven FS, Karlsen OA, Straume AH, Flikka K, Murrell JC, Fjellbirkeland A, Lillehaug JR, Eidhammer I, Jensen HB. 2006. Analysing the outer membrane subproteome of Methylococcus capsulatus (Bath) using proteomics and novel biocomputing tools. Arch. Microbiol. 184:362-377. http://dx.doi.org/10.1007/s00203-005-0055-7.
43. Sachdeva G, Kumar K, Jain P, Ramachandran S. 2005. SPAAN: a software program for prediction of adhesins and adhesin-like proteins using neural networks. Bioinformatics 21:483-491. http://dx.doi.org/10.1093/bioinformatics/bti028.
44. Doytchinova IA, Flower DR. 2007. VaxiJen: a server for prediction of protective antigens, tumour antigens, and subunit vaccines. BMC Bioinformatics 8:4. http://dx.doi.org/10.1186/1471-2105-8-4.
45. Saha S, Raghava GP. 2006. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65:40-48. http://dx.doi.org/10.1002/prot.21078.
46. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M. 2007. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8:424. http://dx.doi.org/10.1186 /1471-2105-8-424.
47. Nielsen M, Lund O. 2009. NN-align: an artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 10:296. http://dx.doi.org/10.1186/1471-2105-10-296.
48. Kalita M, Tian B, Gao B, Choudhary S, Wood TG, Carmical JR, Boldogh I, Mitra S, Minna JD, Brasier AR. 2013. Systems approaches to modeling chronic mucosal inflammation. Biomed. Res. Int. 2013:1-17. http://dx.doi.org/10.1155/2013/505864.
49. Cieza RJ, Cao A, Cong Y, Torres AG. 2012. Immunomodulation for GI infections. Expert Rev. Anti Infect. Ther. 10:391-400. http://dx.doi.org/10.1586/eri.11.176.
50. Barat S, Willer Y, Rizos K, Claudi B, Mazé A, Schemmer AK, Kirchhoff D, Schmidt A, Burton N, Bumann D. 2012. Immunity to intracellular Salmonella depends on surface-associated antigens. PLoS Pathog. 8:e1002966. http://dx.doi.org/10.1371/journal.ppat.1002966.
51. Liang Y, Wu X, Zhang J, Xiao L, Yang Y, Bai X, Yu Q, Li Z, Bi L, Li N, Wu X. 2012. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 66:419-426. http://dx.doi.org/10.1111/1574 -695X.12008.
52. Chen J, Lin L, Li N, She F. 2012. Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids. Microbiol. Immunol. 56:85-92. http://dx.doi.org/10.1111/j.1348-0421.2011.00409.x.
53. Sun Y, Shi W, Yang JY, Zhou DH, Chen YQ, Zhang Y, Yang Y, He BX, Zhong MH, Li YM, Cao Y, Xiao Y, Li W, Yu J, Li YH, Fan MW, Yan HM. 2012. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine. J. Dent. Res. 91:941-947. http://dx.doi.org/10.1177 /0022034512457684.
54. Zhu C, Wang S, Hu S, Yu M, Zeng Y, You X, Xiao J, Wu Y. 2012. Protective efficacy of a Mycoplasma pneumoniae P1C DNA vaccine fused with the B subunit of Escherichia coli heat-labile enterotoxin. Can. J. Microbiol. 58:802-810. http://dx.doi.org/10.1139/w2012-051.
55. Zhu C, Wu Y, Chen S, Yu M, Zeng Y, You X, Xiao J, Wang S. 2012. Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1CDNAvaccine. Can. J. Microbiol. 58:644-652. http://dx.doi.org/10.1139/w2012-041.
56. De Groot AS, Levitz L, Ardito MT, Skowron G, Mayer KH, Buus S, Boyle CM, Martin WD. 2012. Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes. Hum. Vaccine Immunother. 8:987-1000. http://dx.doi.org/10.4161/hv.20528.
57. Babiuk S, Asper DJ, Rogan D, Mutwiri GK, Potter AA. 2008. Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice. Microb. Pathog. 45:7-11. http://dx.doi.org/10.1016/j.micpath.2008.01.005.
58. Fan HY, Wang L, Luo J, Long BG. 2012. Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins. Mol. Biol. Rep. 39:989-997. http://dx.doi.org/10.1007/s11033-011 -0824-0.
59. Fujii J, Naito M, Yutsudo T, Matsumoto S, Heatherly DP, Yamada T, Kobayashi H, Yoshida S, Obrig T. 2012. Protection by a recombinant Mycobacterium bovis bacillus Calmette-Guerin vaccine expressing Shiga toxin 2B subunit against Shiga toxin-producing Escherichia coli in mice. Clin. Vaccine Immunol. 19:1932-1937. http://dx.doi.org/10.1128/CVI.00473-12.
60. Wan CS, Zhou Y, Yu Y, Peng LJ, Zhao W, Zheng XL. 2011. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate. Microbiol. Immunol. 55:247-253. http://dx.doi.org/10.1111/j.1348-0421.2011.00316.x.
61. Amani J, Mousavi SL, Rafati S, Salmanian AH. 2011. Immunogenicity of a plant-derived edible chimeric EspA, intimin, and Tir of Escherichia coli O157:H7 in mice. Plant Sci. 180:620-627. http://dx.doi.org/10.1016/j.plantsci.2011.01.004.
62. Keepers TR, Psotka MA, Gross LK, Obrig TG. 2006. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J. Am. Soc. Nephrol. 17:3404-3414. http://dx.doi.org/10.1681/ASN.2006050419.
63. Mohawk KL, O'Brien AD. 2011. Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection. J. Biomed. Biotechnol. 2011: 258185.
64. Mohawk KL, Melton-Celsa AR, Zangari T, Carroll EE, O'Brien AD. 2010. Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb. Pathog. 48:131-142. http://dx.doi.org/10.1016/j.micpath.2010.01.003.
65. Srivastava IK, Liu MA. 2003. Gene vaccines. Ann. Intern. Med. 138:550-559. http://dx.doi.org/10.7326/0003-4819-138-7-200304010-00011.
66. Cai K, Gao X, Li T, Hou X, Wang Q, Liu H, Xiao L, Tu W, Liu Y, Shi J, Wang H. 2010. Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response. Can. J. Microbiol. 56:389-398. http://dx.doi.org/10.1139/W10 -025.